Tai-Yun Lin

Title: Innovations of Tai-Yun Lin in Cancer Research

Introduction

Tai-Yun Lin is a prominent inventor based in Taipei, Taiwan. He has made significant contributions to the field of cancer research through his innovative work on synthetic peptides targeting cancer stem cells. His research aims to improve therapeutic strategies for cancer treatment.

Latest Patents

Tai-Yun Lin holds two patents, with his latest focusing on a cancer stem cell targeting peptide. This synthetic peptide is designed to specifically target cancer stem cells, consisting of an amino acid sequence from SEQ ID NO: 1 to SEQ ID NO: 15. The patent also includes a composition that combines this synthetic peptide with a therapeutic agent and a pharmaceutically acceptable carrier or diluent. Furthermore, the patent outlines a method for screening peptides that specifically target cancer stem cells, utilizing a phage expression system to establish an oligopeptide library.

Career Highlights

Tai-Yun Lin is affiliated with the Agricultural Technology Research Institute, where he conducts his research. His work has garnered attention for its potential to revolutionize cancer treatment by targeting the root of tumor growth.

Collaborations

He collaborates with notable colleagues, including Chin-Kai Chuang and Yu-Hsyu Su, who contribute to his research endeavors.

Conclusion

Tai-Yun Lin's innovative work in developing cancer stem cell targeting peptides represents a significant advancement in cancer research. His contributions have the potential to lead to more effective treatments for patients battling cancer.